Sonic Healthcare Limited (SKHCF) Fair Value & Analysis
Healthcare · US · Market cap $6.8B
Sonic Healthcare Limited
SKHCF · US
Fair value as of: Jul 18, 2026
From 26 valuation models · updated 5 days ago
Fair value updated Jul 18, 2026, revised from $31.25 to $15.97 (−48.9%) since Jun 24, 2026. Share price +3.3% over the past month.
Price vs Fair Value (12 months)
12‑month range $12.00 – $17.66 · fair‑value band $11.98 – $19.96 · the $13.80 price screens below the $15.97 fair value. As of Jul 18, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Sonic Healthcare Limited (SKHCF) currently trades at $13.80, while our model-based Fair Value estimate is $15.97, implying the stock looks roughly 15.7% undervalued today. We read business quality at 49/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Sonic Healthcare Limited generated revenue of $10.4B at a net margin of 5.2%. Revenue grew 16.6% year over year. It earns a return on equity of 6.6%. Net debt stands at $4.5B. Fundamentals as of Jul 18, 2026
Our scenario range runs from $11.98 (bear case) to $19.96 (bull case); at $13.80, the current price sits within that range. The share trades about 22% below its 52-week high and 15% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -49% fair-value upside, at 16%, SKHCF screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 18, 2026. TTM = trailing twelve months.
About the company
Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It also offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, general practice IT solutions, and community-based healthcare services, as well as clinical trials services. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Sonic Healthcare Limited reported revenue of $9.6B in FY2025 versus $8.8B in FY2021, a compound +2.5%/yr. Reported net income was $514M in FY2025, compounding −20.9%/yr from FY2021.
Is SKHCF fairly valued? → Check now
Recent news
- CellCarta and Sonic Healthcare Establish Strategic Partnership to Commercialize Companion Diagnostics Through Lab Network
- Australia pledges A$1.8 billion for Medicare clinics amid widening deficit fears
- Sonic Healthcare (ASX:SHL) Has More To Do To Multiply In Value Going Forward
- Sonic Healthcare (ASX:SHL) earnings and shareholder returns have been trending downwards for the last five years, but the stock lifts 7.4% t
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection, not financial advice.
Similar stocks
10 more Diagnostics & Research stocks, each showing price versus our Fair Value estimate (as of Jul 18, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Thermo Fisher Scientific Inc TMO | $543.19 | $308.19 | -43% |
| Danaher Corporation DAP | €157.35 | €73.68 | -53% |
| WuXi AppTec Co 2359 | HK$152.80 | HK$120.99 | -21% |
| Lonza Group LONN | CHF 500.40 | CHF 153.08 | -69% |
| IDEXX Laboratories, Inc IDXX | $562.16 | $190.95 | -66% |
| Agilent Technologies, Inc A | $138.37 | $65.93 | -52% |
| Waters Corporation WAT | $358.25 | $106.31 | -70% |
| IQVIA Holdings IQV | $167.81 | $133.89 | -20% |
| Integrated Diagnostics Holdings IDHC | $0.0056 | $0.0100 | +78% |
| Illumina, Inc ILMN | $162.32 | $82.90 | -49% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Sonic Healthcare Limited (SKHCF) undervalued?
What is the fair value of SKHCF?
What is the quality score of SKHCF?
What is the revenue of Sonic Healthcare Limited (SKHCF)?
What is the net profit margin of SKHCF?
Does Sonic Healthcare Limited pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Unlock the full Sonic Healthcare Limited analysis, and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.